Works matching IS 09509232 AND DT 2007 AND VI 26 AND IP 33
Results: 14
Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
- Published in:
- Oncogene, 2007, v. 26, n. 33, p. 4850, doi. 10.1038/sj.onc.1210272
- By:
- Publication type:
- Article
Caspase cleavage of the APC tumor suppressor and release of an amino-terminal domain is required for the transcription-independent function of APC in apoptosis.
- Published in:
- Oncogene, 2007, v. 26, n. 33, p. 4872, doi. 10.1038/sj.onc.1210265
- By:
- Publication type:
- Article
Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells.
- Published in:
- Oncogene, 2007, v. 26, n. 33, p. 4877, doi. 10.1038/sj.onc.1210266
- By:
- Publication type:
- Article
Ras effector pathways modulate scatter factor-stimulated NF-κB signaling and protection against DNA damage.
- Published in:
- Oncogene, 2007, v. 26, n. 33, p. 4774, doi. 10.1038/sj.onc.1210271
- By:
- Publication type:
- Article
Transgenic expression of human thymidylate synthase accelerates the development of hyperplasia and tumors in the endocrine pancreas.
- Published in:
- Oncogene, 2007, v. 26, n. 33, p. 4817, doi. 10.1038/sj.onc.1210273
- By:
- Publication type:
- Article
Akt activation induces epidermal hyperplasia and proliferation of epidermal progenitors.
- Published in:
- Oncogene, 2007, v. 26, n. 33, p. 4882, doi. 10.1038/sj.onc.1210274
- By:
- Publication type:
- Article
Adenoviral E1B55K oncoprotein sequesters candidate leukemia suppressor sequence-specific single-stranded DNA-binding protein 2 into aggresomes.
- Published in:
- Oncogene, 2007, v. 26, n. 33, p. 4797, doi. 10.1038/sj.onc.1210281
- By:
- Publication type:
- Article
HEI10 negatively regulates cell invasion by inhibiting cyclin B/Cdk1 and other promotility proteins.
- Published in:
- Oncogene, 2007, v. 26, n. 33, p. 4825, doi. 10.1038/sj.onc.1210282
- By:
- Publication type:
- Article
Dose–response transition from cell cycle arrest to apoptosis with selective degradation of Mdm2 and p21<sup>WAF1/CIP1</sup> in response to the novel anticancer agent, aminoflavone (NSC 686288).
- Published in:
- Oncogene, 2007, v. 26, n. 33, p. 4806, doi. 10.1038/sj.onc.1210283
- By:
- Publication type:
- Article
Xeroderma pigmentosum group C gene expression is predominantly regulated by promoter hypermethylation and contributes to p53 mutation in lung cancers.
- Published in:
- Oncogene, 2007, v. 26, n. 33, p. 4761, doi. 10.1038/sj.onc.1210284
- By:
- Publication type:
- Article
JunB is a gatekeeper for B-lymphoid leukemia.
- Published in:
- Oncogene, 2007, v. 26, n. 33, p. 4863, doi. 10.1038/sj.onc.1210285
- By:
- Publication type:
- Article
Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon.
- Published in:
- Oncogene, 2007, v. 26, n. 33, p. 4833, doi. 10.1038/sj.onc.1210286
- By:
- Publication type:
- Article
GRIM-19 associates with the serine protease HtrA2 for promoting cell death.
- Published in:
- Oncogene, 2007, v. 26, n. 33, p. 4842, doi. 10.1038/sj.onc.1210287
- By:
- Publication type:
- Article
Clock and ATF4 transcription system regulates drug resistance in human cancer cell lines.
- Published in:
- Oncogene, 2007, v. 26, n. 33, p. 4749, doi. 10.1038/sj.onc.1210289
- By:
- Publication type:
- Article